Device and Method for Injecting Fluids or Gels
Claim Score by NHIP
Abstract
A device for successively injecting material at predetermined distances between successive injections to body tissue along a desired path of skin surface includes an injector sub-assembly having a needle configured for injecting the material into body tissue, and a displacement sub-assembly configured to facilitate precise displacement of the needle or of the device along the path between successive injections.

Term
4.8 yearsto projected expiry
Projected expiry 13 July 2031, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
33 claims: 1 independent, 32 dependent
- 1Broadest claimClaim Score 83, broad(NHIP)A device for successively injecting material at predetermined distances between successive injections to body tissue along a desired path of skin surface, said device comprising:an injector sub-assembly having a needle configured for injecting said material into body tissue, and a displacement sub-assembly configured to facilitate precise displacement of the needle or of the device along said path between successive injections.
98 paragraphs in 6 sections, as filed
RELATED APPLICATION
0001This application claims benefit of provisional application Ser. No. 61/315,964 filed Mar. 21, 2010 whose contents are included herein by reference.
FIELD OF THE INVENTION
0002This invention relates to a device or system and method for the delivery of fluids or gels by injection into or underneath the human skin for wrinkle treatment or for other purposes.
BACKGROUND OF THE INVENTION
0003A wide range of subcutaneous drug delivery devices is known.
0004Several years ago the needs of society in the medical field were different from today's needs and the technology abilities then were also different from modern technology. In the 1950's there was a very big need to treat diabetes mellitus with self-administered insulin injections. These needs were met by several devices, whose purpose was to allow a person to administer self injections of the drug at home. Such devices are disclosed, for example, by U.S. Pat. No. 2,660,169 titled “Devices for supporting and operating hypodermic syringes and injecting a fluid into the body”. The device is very simple, with no electronics in it, operated by manual pressure only. Its only function is to inject the whole contents of the syringe at once into the patient.
0005Later, in the 1970's another need arose—to vaccinate a large population in a short period of time. This need was addressed by “gun-like” injection devices, such as disclosed in U.S. Pat. No. 3,727,614, which discloses a multiple dosage inoculator for administrating vaccines, where the vacuum is used to draw the skin of the patient onto the needle using only one hand.
0006Another “gun-like” injection device adapted for the self-injection of insulin is disclosed in U.S. Pat. No. 4,067,334. This device is manually operated. The syringe is connected to a spring, that allows its movement, and a drug is injected by releasing the air pressure contained in the bulb, operated by the user.
0007Another field of the medicine/cosmetic treatments that was developed around the 1980's is mesotherapy. U.S. Pat. No. 4,108,177 discloses a gun-like device, operated by an electro-magnet and a motor. This is the first invention that uses an electric mechanism to create motion. The device is able to perform many injections in a short period of time, and create very fast syringe motion and very fast fluid injection.
0008U.S. Pat. No. 4,512,767 discloses a gun-like mesotherapy mechanical injection device, which includes means for positioning the penetration needle and to predetermine the degree of penetration of the needle.
0009U.S. Pat. No. 4,790,823 discloses another such device having an optical sight for a precise needle direction and a micro-controller for controlling the quantity of the injected fluid and the speed of injection.
0010U.S. Pat. No. 4,600,403 discloses a suction injector where an electric motor is used to create suction. The injection is triggered by the skin, as soon as it has been raised high enough and the amount of injected fluid is electronically controlled.
0011In U.S. Pat. No. 4,833,384 a motor is coupled to a lead screw that moves a syringe plunger whose position is accurately controlled by a digital encoder.
0012A very important factor in automatic injection devices is the need to control needle penetration depth. One solution is taught by U.S. Pat. No. 5,015,235 where the user selects an adjuster from a set of adjusters of different sizes and fits it over a part of a hub.
0013U.S. Pat. No. 5,690,618 discloses an electronic syringe for administrating anesthetic injections, particularly suited in dental applications where a precise level of hand control is required. A drive means is provided in electrical communication with an electronic controller, which controls the amount of the injected fluid and the injection flow rate.
0014U.S. Pat. No. Re. 35,986 discloses an automatic injector having two chambers containing different ingredients of medicament separated by a membrane and mixed during injection. Needle penetration depth is limited by placing a disc on the needle.
0015U.S. Pat. No. 5,906,592 discloses a device for accurately infusing fluids into a patient at specific rates over an extended period of time.
0016U.S. Pat. No. 5,921,962 discloses an injection device having a flow indicator that provides an indication at any given time about the amount of fluid remaining in the device.
0017U.S. Pat. No. 6,994,691 discloses an injection device for making injection at a predetermined depth in skin. A skin positioning member is positioned on a patch of skin within an area of skin such that at least a part of the patch of skin may be held elevated above or depressed below the area of skin. A guidance mechanism guides an injection needle to slide beneath the skin positioning member to an injection position.
0018As it can be seen in the prior art study, known injection devices are able to penetrate the skin perpendicularly, but they cannot perform a series of injections while controlling the distance between those injections; neither can they control the needle penetration speed. For all the reasons listed above, filler injection procedures are being performed manually.
0019The problem of the filler's manual injections methods used in today's practice is that the needle penetration is done in parallel to the skin surface. In that way consequently, it is very difficult to control the injection depth accurately and to control the amount of the injected drug/filler. Moreover, it is difficult or impossible to maintain the layer of the injected drug/filler under the skin surface uniform without lumps. Additionally, the procedure is painful owing to internal skin tissue tearing and patient bleeding due to the blood vessels injury. Also, it is difficult to avoid swelling, pain and redness following treatment.
0020Additionally, it emerges from the prior art review that there is a need for an advanced injection device able to control the speed of needle penetration into the skin. There is a need for the device to be able to control the depth of needle penetration, injection flow rate, and the volume of the injected fluid or gel.
0021There is a need for the device to be painless, able to perform a series of injections, to control the distance between those injections, and to be capable of computer control or/and manual control.
0022The present invention overcomes the disadvantages of the injection devices associated with prior art drug delivery devices, the disadvantages of the devices existing on today's market and the disadvantages of manual injecting of drugs or fillers.
SUMMARY OF THE INVENTION
0023In accordance with the invention there is provided a device for successively injecting material at predetermined distances between successive injections to body tissue along a desired path of skin surface, said device comprising:
0024an injector sub-assembly having a needle configured for injecting said material into body tissue, and
0025a displacement sub-assembly configured to facilitate precise displacement of the needle or of the device along said path between successive injections.
0026The invention thus principally resides in a device that is adapted to inject a needle into a surface of the skin to a required depth of penetration for injecting a required amount of material and which is adapted to move the needle by a required displacement between successive injections.
0027According to this invention there is provided a device or system and method of delivery of fluids or gels by injection into or underneath the epidermis layer, or into or underneath the dermis layer of human beings.
0028The device allows injecting the fluid or gel to a predetermined, settable or controllable depth under the skin surface either for wrinkle treatment or for other purposes thus avoiding blood vessels injury.
0029The device allows the treated skin area to be subjected to a series of injections along a desired path at a predetermined, settable or controllable distance between the injections. The device also allows a predetermined, settable or controllable amount of fluid or gel to be injected in each injection, thereby achieving a uniform layer of fluid or gel. The device further allows injecting the fluid or gel at a predetermined, settable or controllable flow rate.
0030The injection needle is very thin (32 G and above) in order to minimize the injury to the patient's skin.
0031In some embodiments, the device allows the speed of needle penetration into the skin to be predetermined, settable or controllable speed thus allowing use of very thin needles (32 G and above).
0032In some embodiments, the device may be used to inject one of the currently available fillers for wrinkle treatment. The device includes a thin needle attached to either a syringe or to a container, containing the fluid or gel to be injected.
0033In some embodiments, the injections can be carried out by a needle, or alternatively by a group of two or more needles linked to the fluid/gel syringe or container.
0034In some embodiments, the device includes a mechanism, which controls the injecting mechanism movement and the speed of needle penetration into the skin. The device includes another mechanism whose purpose is to limit or set the needle's penetration depth beneath the skin surface.
0035In one embodiment, the device includes a mechanical stopper, which stops the needle penetration once it touches the skin surface.
0036Alternatively, a mechanical end-stop may be mounted on the needle in fixed spatial relationship with an end thereof. For example, a disc may be mounted on the needle to limit the depth of needle penetration into the skin.
0037In some embodiments this mechanism is based on a sensor or micro-switch, that detects contact with the skin surface once the needle has penetrated a desired depth beneath the skin surface, and stops the needle insertion.
0038In some embodiments, a muzzle surrounds the needle and a vacuum source draws the patient's skin into the muzzle in order to perform the injection.
0039The device includes a mechanism for pushing the liquid or gel contained in the syringe or the container, so when this mechanism is activated, the liquid or gel is injected through the needle into the treated area. This mechanism is able to inject a predetermined, settable or controllable amount of fluid or gel at a predetermined, settable or controllable flow rate in each injection.
0040In some embodiments, the device indicates the user about the amount of fluid or gel containing in the syringe or container.
0041The device includes a mechanism, which causes the device to advance a predetermined, settable or controllable distance between injections.
0042In some embodiments, the user directs the device along the desired treatment path (along a wrinkle for instance) manually, using a mechanical or optical pointer attached to the device.
0043Alternatively, the device is capable to move forward automatically along the treatment path without external manual interaction by the user.
0044In some embodiments, the device includes an optical sensor such as a camera, connected to an external TV set, screen or computer, so the image captured by the optical sensor can be seen on the screen. This allows the operator to direct the device more precisely.
0045In some embodiments, the desired treatment path is dictated by using an optical sensor. The device controller controls the advancement direction of device by analyzing the data received from the optical sensor in such a way that the device follows and treats the desired treatment path, such as a skin wrinkle.
0046In such an embodiment the device is capable to move forward along the desired treatment path automatically.
0047In some embodiments, the device comprises a light source, such as, but not limited to, one or more LED's located close to the needle or the injection place in order to improve visibility of the treated area by the person carrying out the treatment.
0048In some embodiments, the device includes a massaging mechanism for massaging the already treated skin area. The massaging mechanism is located behind the syringe and the needle, so that each time it is activated, it massages a different treated skin area along the treatment path.
0049In some embodiments, the user can manually select the device operation mode according to the needed treatment. For instance, for wrinkle filling the user may select shallow, medium or deep wrinkle setting. The device controller sets the injection filler quantity to be injected each time, the needle's penetration depth, the distance between consecutive injections and the massaging session duration according to the selected setting.
0050In some embodiments, the user can manually select the flow rate of the gel or fluid according to the needed treatment.
0051In some embodiments the device controller analyzes the data received from an optical, electronic or mechanical sensor, estimates the wrinkle depth and sets accordingly the injection filler quantity to be injected each time, the injecting flow rate, the needle's penetration depth, the distance between consecutive injections and the massaging session duration.
0052In some embodiments, the device includes a mechanism which allows also a widthwise motion of the described above mechanism, so a skin area can be treated by applying a matrix-like pattern of injections rather than a linear path of injections.
BRIEF DESCRIPTION OF THE DRAWINGS
0053In order to understand the invention and to see how it may be carried out in practice, embodiments will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:
0054<figref idrefs="DRAWINGS">FIG. 1</figref> is a schematic view showing the principal sub-assemblies in a device according to the invention;
0055<figref idrefs="DRAWINGS">FIG. 2</figref> is a perspective view of a base sub-assembly and injector sub assembly with a syringe mounted in its place;
0056<figref idrefs="DRAWINGS">FIG. 3</figref> is a perspective view of the injector sub-assembly;
0057<figref idrefs="DRAWINGS">FIG. 4</figref> is a perspective partial view of the device showing in greater detail the displacement control sub-assembly;
0058<figref idrefs="DRAWINGS">FIGS. 5</figref><i>a </i>and <b>5</b><i>b </i>show details of a linkage that induces relative movement between the injector sub assembly and the displacement control sub-assembly;
0059<figref idrefs="DRAWINGS">FIG. 6</figref> is a detailed view of the displacement control sub-assembly and the electronic printed circuit board;
0060<figref idrefs="DRAWINGS">FIG. 7</figref><i>a </i>is a partial detailed view of the device in use;
0061<figref idrefs="DRAWINGS">FIG. 7</figref><i>b </i>shows detailed views of the needle and the injection depth limiter when separated;
0062<figref idrefs="DRAWINGS">FIGS. 8</figref><i>a </i>and <b>8</b><i>b </i>is a schematic diagram of an electronic circuit used to control the device; and
0063<figref idrefs="DRAWINGS">FIG. 9</figref> is a flow diagram showing the principal operations carried out during operation of the device.
DETAILED DESCRIPTION OF EMBODIMENTS
0064Mechanical System Description
0065<figref idrefs="DRAWINGS">FIG. 1</figref> shows schematically a device <b>100</b> according to the invention comprising four sub-assemblies, namely an enclosure <b>1</b>, a base <b>200</b> shown in <figref idrefs="DRAWINGS">FIG. 2</figref>, an injector sub-assembly <b>300</b> shown in <figref idrefs="DRAWINGS">FIG. 3</figref> and a displacement control sub-assembly <b>400</b> shown in <figref idrefs="DRAWINGS">FIG. 4</figref>. The base sub-assembly <b>200</b> serves to move an injection needle <b>30</b> into close proximity to the skin being treated and to advance the needle to a controlled depth of penetration. The injector sub-assembly <b>300</b> serves to inject a controlled amount of material into or beneath the skin. The displacement control sub-assembly <b>400</b> is adapted to operate only when the injector sub-assembly <b>300</b> is retracted (so that the needle is withdrawn) and serves to advance the device a controlled distance along the skin prior to the next injection of additional material.
0066The enclosure <b>1</b> is in the shape of a box from one side of which there protrudes a transparent polycarbonate pipe <b>5</b>. In order to start the treatment, the transparent pipe <b>5</b> is perpendicularly placed in contact with the treated person's skin <b>51</b> (shown in <figref idrefs="DRAWINGS">FIG. 7</figref><i>a</i>) directly over an area to be treated (typically a wrinkle). By doing this, the base <b>200</b> is located at the correct distance from the treated person's skin <b>51</b>. The pipe <b>5</b> thus constitutes a safety stop that at least partially surrounds the end of the needle and prevents inadvertent penetration thereof. The enclosure <b>1</b> further comprises an on-off switch <b>2</b>, a power connector <b>3</b> for allowing connection of the unit to an external power supply, a data connector <b>4</b> for allowing connection of the unit to a computer and ventilation openings <b>6</b>.
0067The function of the base <b>200</b> is to support and drive the injector <b>300</b> and the displacement control unit <b>400</b>, as well as to support an electronic circuit by means of which the device is controlled.
0068The base <b>200</b>, which is fixed to the enclosure <b>1</b>, includes a base plate <b>7</b> that is folded at two adjacent edges to form first and second mutually perpendicular support surfaces that are each perpendicular to the base plate <b>7</b>, the first at an end thereof for supporting a stepper motor <b>8</b> (constituting a first drive unit) and the second at a side thereof for supporting a linear bearing <b>37</b>. A shaft of the stepper motor <b>8</b> is coupled to a screw rod <b>10</b>, which threadably engages a pair of nuts <b>49</b><i>a </i>and <b>49</b><i>b </i>(shown in <figref idrefs="DRAWINGS">FIGS. 5</figref><i>a </i>and <b>5</b><i>b</i>), fixed to a carriage <b>14</b> that supports the injector sub-assembly <b>300</b> so that rotation of the motor shaft induces linear motion of the injector. The carriage <b>14</b> is slidably supported within a linear bearing <b>11</b> fixed to the base plate <b>7</b> and comprises nut holders <b>12</b> and <b>13</b>, an electrical contact <b>15</b> and it supports an injector base plate <b>19</b>. The base plate <b>7</b> also supports, a linear bearing <b>37</b> slidably supporting the displacement control unit <b>400</b>, a rotary bearing <b>41</b> (shown in <figref idrefs="DRAWINGS">FIG. 4</figref>) supporting a lever <b>18</b>, an electronic PCB <b>54</b> (shown in <figref idrefs="DRAWINGS">FIG. 6</figref>) and two electrical limit switch contacts <b>16</b> and <b>17</b>.
0069The attachment of the stepper motor <b>8</b> to the base plate <b>7</b> allows for a limited amount of flexibility, achieved through rubber discs <b>9</b>. This compensates for slight inaccuracies and misalignments without creating distortion of mechanical parts or causing stress or friction between the screw rod <b>10</b> and the nuts <b>49</b><i>a </i>and <b>49</b><i>b </i>during rotation of the stepper motor <b>8</b>.
0070When the stepper motor <b>8</b> rotates, it moves the nuts <b>49</b><i>a </i>and <b>49</b><i>b</i>, which are supported by the nut holders <b>12</b> and <b>13</b>, consequently shifting the carriage <b>14</b> supporting the injector sub-assembly <b>300</b> along the screw rod <b>10</b>. The extent of this movement is limited: at the retracted “home” position, a contact <b>15</b> fixed to the carriage and constituting a moving contact <b>14</b> makes electrical contact with the switch contact <b>17</b>, which is mounted on a rubber isolator glued to the base plate <b>7</b> thus closing an electrical switch comprising contacts <b>15</b> and <b>17</b>. At the extended “end of travel” position, the carriage <b>14</b> makes electrical contact with the switch contact <b>16</b>, which is mounted on a rubber isolator glued to a bracket <b>56</b> fixed to the base plate <b>7</b> thus closing an electrical switch comprising contacts <b>15</b> and <b>16</b>. In this way, the stepper motor <b>8</b> can be controlled to move within its movement range without exceeding it. Rotating the stepper motor <b>8</b> in a clockwise direction will move the injector sub-assembly towards its extended “end of travel” position, while rotating it in a counter-clockwise direction will move the injector sub-assembly towards its retracted “home” position.
0071Injector aligners <b>47</b> and <b>48</b> (shown in <figref idrefs="DRAWINGS">FIG. 4</figref>) allow the injector sub-assembly <b>300</b> mounted on the carriage <b>14</b> to move linearly along its path, thereby avoiding any undesired moment in the linear bearing <b>11</b> due to lateral forces such as the injector weight.
0072During normal operation the injector sub-assembly <b>300</b> is periodically moved from its “home” position towards its “end of travel” position, without reaching it, and back to the “home” position.
0073During the movement towards the “end of travel” position, a needle <b>30</b> supported by the injector sub-assembly <b>300</b> is inserted a predetermined depth into the skin <b>51</b>. The length of the transparent pipe <b>5</b> in the enclosure is such that when the needle <b>30</b> is in its inserted position, the “end of travel” position is not yet reached. The “end of travel” contact <b>16</b> provides a security means for avoiding mechanical overdrive of the carriage <b>14</b> within the linear bearing <b>11</b> beyond its permitted range of movement.
0074As can be seen in <figref idrefs="DRAWINGS">FIGS. 2</figref>, <b>3</b>, <b>4</b> and <b>5</b>, a pin <b>31</b> protrudes outward from a side surface of the injector sub-assembly <b>300</b> and engages an upper slot within a lever arm <b>18</b> that is pivotally mounted by a rotary bearing <b>41</b>, which is fixed to the second surface at the side of the base <b>7</b>. In similar manner, a lower slot in the lever arm <b>18</b> engages a pin <b>50</b> that protrudes outwardly from the displacement control sub-assembly <b>400</b>. Pin <b>50</b> is attached to a support plate <b>36</b> that is slidably supported within the linear bearing <b>37</b>, which is fixed to the second surface at the side of the base <b>7</b>. As the injector sub-assembly <b>300</b> moves in a first direction within the linear bearing <b>11</b>, the pin <b>31</b> induces rotation of the lever arm <b>18</b> thereby causing the displacement control sub-assembly <b>400</b> to move in the opposite direction as shown in <figref idrefs="DRAWINGS">FIGS. 5</figref><i>a </i>and <b>5</b><i>b</i>. In this way, when the injector sub-assembly <b>300</b> is extracted towards the skin <b>51</b> in order to inject, the displacement control sub-assembly <b>400</b> is retracted backwards away from the skin <b>51</b>, and when the injector sub-assembly is retracted backwards towards its “home” position, the displacement control sub-assembly <b>400</b> is extracted towards the skin <b>51</b>.
0075The injector sub-assembly <b>300</b> serves to support a syringe <b>27</b> (constituting a container for storing a reservoir of material) and to shift a piston <b>28</b> therein, which is pushed in such way that a precise amount of the syringe's contents is injected into the treated skin <b>51</b> at a precise flow rate during each injection while allowing the needle <b>30</b> to penetrate the skin <b>51</b> to a precise, predetermined depth.
0076As seen best in <figref idrefs="DRAWINGS">FIG. 3</figref>, the injector sub-assembly <b>300</b> comprises a base <b>19</b> supporting mutually perpendicular opposing side support surfaces and an end support surface. Mounted on the end support surface is a stepper motor <b>20</b> (constituting a second drive unit) whose shaft is coupled to a screw rod <b>21</b>. The syringe <b>27</b> is supported within opposing syringe holders <b>25</b> and <b>26</b> protruding from an end of the base <b>19</b> opposite the stepper motor <b>20</b>. A piston shifter <b>23</b> is slidably supported within a linear bearing <b>22</b> mounted on the base <b>19</b> and supports a nuts holder <b>24</b>. Nuts <b>49</b><i>c </i>and <b>49</b><i>d </i>(shown in <figref idrefs="DRAWINGS">FIGS. 5</figref><i>a </i>and <b>5</b><i>b</i>) fixed to the nuts holder <b>24</b> are threadably supported on the screw rod <b>21</b> so that rotation of the stepper motor <b>20</b> induces linear movement of the piston shifter <b>23</b>. The piston shifter constitutes a release unit operable by the second drive unit for releasing a desired quantity of material from the container.
0077The extent of this movement is limited. At the retracted “home” position, the piston shifter <b>23</b> makes electrical contact with the switch contact <b>34</b>, which is mounted on a rubber isolator glued to the injector's base plate <b>19</b> proximate the stepper motor <b>20</b>, thus closing an electrical switch comprising the contact <b>34</b> that is fixed to the base plate <b>19</b> and a contact <b>32</b> that is fixed to the piston shifter <b>23</b>. The piston shifter <b>23</b> is formed of electrically conductive material and is electrically coupled to the switch contact <b>32</b>. At its extended “end of travel” position, the piston shifter <b>23</b> makes electrical contact with a switch contact <b>33</b>, which is mounted on a rubber isolator glued to the end of travel contact holder <b>57</b>, thus closing an electrical switch comprising contacts <b>32</b> and <b>33</b>. In this way, the stepper motor <b>20</b> can be controlled to move the piston shifter <b>23</b> within its movement range without exceeding it. Rotating the stepper motor <b>20</b> in a counter-clockwise direction will move the piston shifter <b>23</b> towards its retracted “home” position, conveniently allowing the user to install the syringe <b>27</b> in its place and to secure it by tightening the screws that hold the syringe holder <b>26</b>. Rotating the stepper motor <b>20</b> in a clockwise direction will move the piston shifter towards its extended “end of travel” position, advancing towards the syringe's piston <b>28</b>. Once the piston shifter <b>23</b> reaches the piston <b>28</b>, it makes electrical contact with the switch contact <b>35</b>, which is mounted on the piston thus closing an electrical switch comprising the contact <b>35</b> and a contact <b>32</b> that is fixed to the piston shifter <b>23</b>. This allows the stepper motor <b>20</b> to be controlled to quickly advance the piston shifter <b>23</b> until it reaches the piston <b>28</b>, and afterwards to move forward slowly injecting a precise amount of the syringe's contents into the treated skin <b>51</b> at a precise, controlled flow rate.
0078The “end of travel” contact <b>33</b> is located in such position that the piston shifter <b>23</b> will reach and make contact with it a short distance before the syringe's piston <b>28</b> reaches the end of the syringe <b>27</b>, thus avoiding mechanical overdrive of the piston shifter <b>23</b>. This contact may also serve as an “Empty Syringe” alarm activation signal.
0079An injection depth limiter as depicted in <figref idrefs="DRAWINGS">FIGS. 7</figref><i>a </i>and <b>7</b><i>b </i>is provided. The injection depth limiter's role is to enable the control of the injector's movement while the needle <b>30</b> is inserted into the skin <b>51</b>, so it penetrates the skin <b>51</b> down to a precise, controlled depth.
0080<figref idrefs="DRAWINGS">FIG. 4</figref> shows in greater detail the displacement control sub-assembly <b>400</b>, which comprises a generally L-shaped advancement lever holder <b>39</b> pivotally mounted on bearing <b>45</b> and urged into a rest position where it engages a limiter <b>40</b> by a spring <b>44</b>. As explained above with reference to <figref idrefs="DRAWINGS">FIGS. 5</figref><i>a </i>and <b>5</b><i>b</i>, the displacement control sub-assembly <b>400</b> is articulated to the injector sub-assembly <b>300</b> by the lever arm <b>18</b> so that when the injector sub-assembly <b>300</b> is retracted away from the skin, the displacement control sub-assembly <b>400</b> is moved toward the skin. When this happens, an advancement feeler lever <b>38</b> attached to a horizontal portion of the advancement feeler lever holder <b>39</b> is brought into contact with the skin <b>51</b>. In addition to that an electrical circuit provides an audible “beep” for alerting the user that the injection needle is withdrawn and prompting him or her to manually move the device along the treatment path to the next location for a subsequent injection.
0081Downward movement of the device along the treatment path while the advancement feeler lever <b>38</b> is in contact with the skin <b>51</b> induces clockwise rotation of the displacement control sub-assembly <b>400</b> about the bearing <b>45</b>, causing the advancement lever holder <b>39</b> to rotate clockwise and to be raised above the limiter <b>40</b> against the biasing force of the spring <b>44</b>. Rotation of the displacement control sub-assembly <b>400</b> also causes a lever <b>43</b> fixed to the vertical portion of the advancement lever holder <b>39</b> to rotate so that a lower end of the lever <b>43</b> is brought into the path of an optical sensor <b>46</b>. When this happens, circuitry coupled to the optical sensor <b>46</b> is adapted to provide another audible “beep” for alerting the user that the device is now located at the correct position for the next injection and prompting him or her to stop downward movement of the device. In actual use, the device is oriented so that the spring <b>44</b> is substantially parallel to the treatment path.
0082As the device is advanced along the path to be treated and advancement lever holder <b>39</b> moves, the spring <b>44</b> is further extended. When the device has reached the position for the next injection, the injector sub-assembly is extracted thus retracting the displacement control sub-assembly <b>400</b> owing to their interconnection via the lever arm <b>18</b>. When the advancement feeler lever <b>38</b> loses its contact with the skin <b>51</b>, the spring <b>44</b> returns the advancement lever holder <b>39</b> to its rest position. This rest position is determined by the limiter <b>40</b> position, which is adjustable. Once the advancement lever holder <b>39</b> and the advancement feeler lever <b>38</b> are back in their rest position, the device is ready for the next cycle.
0083The position of the lever <b>43</b> is adjustable such that the distance it has to travel before intercepting the optical sensor <b>46</b> can be varied. In this way the distance between consecutive injections can be set. In another embodiment, this adjustment may include a small motor, or any other means to enable control of the distance between consecutive injections once the device is activated, or while the device is operating.
0084The displacement control sub-assembly <b>400</b> serves to allow for a predetermined distance between consecutive injections along the treated path.
0085In the embodiment shown in the figures, the device is advanced along the treatment path manually, while the person holding the device is alerted when the device has to be shifted, and when movement of the device has to be stopped as it has reached the position for the next injection. In this way a predetermined distance between consecutive injections is achieved. In other embodiments, the device may include a motor or any other mechanical provision for moving the device a predetermined distance between consecutive injections.
0086<figref idrefs="DRAWINGS">FIGS. 7</figref><i>a </i>and <b>7</b><i>b </i>show details of an injection depth limiter having two mutually insulated contacts <b>53</b><i>a </i>and <b>53</b><i>b </i>which are supported by a plastic electrically insulating tube <b>52</b>, of complementary shape to a base <b>29</b> of the needle <b>30</b>, so that when mounted on the needle's base <b>29</b> the contacts <b>53</b><i>a </i>and <b>53</b><i>b </i>are always at the same distance from the end of the needle. In this way when the needle <b>30</b> penetrates the skin <b>51</b> to the correct depth, both contacts <b>53</b><i>a </i>and <b>53</b><i>b </i>touch the skin <b>51</b>. The contacts <b>53</b><i>a </i>and <b>53</b><i>b </i>detect skin conductivity between them and serve as a skin sensor by means of which the electronic circuit shown in <figref idrefs="DRAWINGS">FIGS. 8</figref><i>a </i>and <b>8</b><i>b </i>sends a signal to the controller within motor <b>8</b> and controller stops the needle's insertion into the skin, thus achieving a precise depth of injection. Furthermore, the plastic tube <b>52</b> not only supports the contacts <b>53</b><i>a </i>and <b>53</b><i>b</i>, but also has the mechanical role of physically limiting the injection depth, ensuring improved safety for the treated person.
0087<figref idrefs="DRAWINGS">FIG. 7</figref><i>b </i>shows in enlarged scale a detail of the depth limiter and the needle prior to engagement. A “V” shaped bore in the end of the plastic tube <b>52</b> intermediate the two contacts <b>53</b><i>a </i>and <b>53</b><i>b</i>, serves to avoid the unwanted creation of a continuous wet pattern between the two contacts which might result in a residual conductance that would jeopardize the correct operation of the depth limiter.
0088In the embodiment shown in the figures, the insertion depth is fixed depending on the geometry of the injection depth limiter, but it is possible to implement other embodiments, which use a different kind of injection depth limiter so the injection depth will be controllable during the operation of the device. Other embodiments may use an injection depth limiter based only on mechanical components.
0089Operation of the device during actual use will now be described with reference to the schematic circuit diagram shown <figref idrefs="DRAWINGS">FIGS. 8</figref><i>a</i>, <b>8</b><i>b </i>and the flow chart shown in <figref idrefs="DRAWINGS">FIGS. 9</figref><i>a</i>, <b>9</b><i>b. </i>
0090Operation of Motor <b>8</b> for Control of Carriage <b>14</b> of Injector Sub-Assembly <b>300</b>: <ul><li id="ul0001-0001" num="0000"><ul><li id="ul0002-0001" num="0091">1. A user programs the motion profile of the motor <b>8</b>: nominal current, holding current, microstep size, acceleration and velocity.</li><li id="ul0002-0002" num="0092">2. The motor <b>8</b> turns counter-clockwise and retracts the injector sub-assembly <b>300</b> to its fully retracted “home” position. When the injector sub-assembly <b>300</b> reaches this position, it touches the limit switch contact <b>17</b>, thereby shorting pins <b>1</b> and <b>2</b> of connector J<b>8</b>, and as a result input <b>3</b> fed to connector J<b>3</b> pin <b>7</b> changes from “1” to “0”. Additionally, the same signal enters pin <b>1</b> of U<b>5</b> (74HC160) and, as a result, the user hears one short buzzer beep.</li><li id="ul0002-0003" num="0093">3. The motor <b>8</b> turns clockwise and extracts the injector sub-assembly <b>300</b> until the contacts <b>53</b><i>a </i>and <b>53</b><i>b </i>of the skin sensor detect contact with the skin. The skin contact sensor is connected to a connector J<b>2</b> a first of whose pins is at positive potential and to a second of whose inputs a transistor Q<b>1</b> is connected, such that Q<b>1</b> starts conducting only when the sensor is contacting a skin surface. When Q<b>1</b> conducts, transistor Q<b>2</b> is likewise biased into conduction and a signal I/O<b>2</b> fed to pin <b>4</b> of connector J<b>3</b> changes from “0” to “1”.</li><li id="ul0002-0004" num="0094">4. The motor <b>8</b> keeps checking the signal I/O<b>1</b> at pin <b>2</b> of connector J<b>3</b> and waits until it changes from “1” to “0” when the motor <b>20</b> has finished injecting.</li><li id="ul0002-0005" num="0095">5. The motor <b>8</b> turns counter clockwise and retracts the injector sub-assembly <b>300</b> to its retracted “Home” position. When the injecting mechanism reaches its retracted position, it contacts the switch contact <b>34</b>, thereby shorting pins <b>1</b> and <b>2</b> of connector J<b>8</b>. As a result an input <b>3</b> fed to pin <b>7</b> of connector J<b>3</b> changes from “1” to “0”. In addition, the same signal is fed to pin <b>1</b> of U<b>5</b> (74HC160) and, as a result, the user hears one short buzzer beep. This short beep is a sign for a user to advance the device along the treated path.</li><li id="ul0002-0006" num="0096">6. The motor <b>8</b> checks the signal IN<b>2</b> fed to pin <b>5</b> of connector J<b>3</b>. A user moves the device forward along the wrinkle. When the device has advanced sufficiently, the signal at pin <b>4</b> of connector J<b>6</b> changes from “1” to “0”. This signal is fed to pin <b>9</b> of U<b>5</b> (74HC160). As a result two things occur: the user hears a long buzzer beep and stops the device advancing; and the signal at pin <b>5</b> of connector J<b>3</b> changes from “0” to “1”. When this input changes to “1”, the motor's processor knows that the device had finished its movement forward along the wrinkle</li><li id="ul0002-0007" num="0097">7. After step 6 the program jumps again to step 3.</li></ul></li></ul>
0098Operation of Motor <b>20</b> for Control of Piston Shifter <ul><li id="ul0003-0001" num="0000"><ul><li id="ul0004-0001" num="0099">1. Programming the motion profile of the motor <b>20</b>: nominal current, holding current, microstep size, acceleration and velocity.</li><li id="ul0004-0002" num="0100">2. The motor <b>20</b> turns counter-clockwise and retracts the piston shifter <b>23</b> to its fully retracted “Home” position, where it contacts the switch contact <b>34</b>. As a result pins <b>1</b> and <b>2</b> of connector J<b>9</b> are shorted, and input <b>3</b> fed to pin <b>7</b> of connector J<b>4</b> changes from “1” to “0”.</li><li id="ul0004-0003" num="0101">3. The motor <b>20</b> turns clockwise and advances the piston shifter <b>23</b> until it contacts the piston. The switch contact <b>35</b> mounted on the piston <b>28</b> is then connected to pin <b>1</b> of connector J<b>10</b>. When the piston shifter <b>23</b> contacts the switch contact <b>35</b>, pins <b>1</b> and <b>2</b> of connector J<b>10</b> are shorted, and as a result, contacts of a relay K<b>2</b> are closed, and remain closed until the device power is down. When the relay K<b>2</b> is closed, the signal I/O<b>2</b> fed to pin <b>4</b> of connector J<b>4</b> changes from “0” to “1”.</li><li id="ul0004-0004" num="0102">4. The velocity is reprogrammed to lower velocity, for slow injection flow rate.</li><li id="ul0004-0005" num="0103">5. The output I/O<b>1</b> of the motor <b>20</b> is programmed to “1” and is fed to the motor <b>8</b>.</li><li id="ul0004-0006" num="0104">6. The motor <b>20</b> waits until the skin contact sensor <b>53</b> detects contact with the skin. As explained above, the skin contact sensor <b>53</b> is connected to J<b>2</b> and the transistor Q<b>1</b> connected to pin <b>2</b> of connector J<b>2</b> starts conducting only when the sensor <b>53</b> makes contact with the surface of the skin. As a result signal IN<b>2</b> at pin <b>5</b> of connector J<b>4</b> changes from “0” to “1”.</li><li id="ul0004-0007" num="0105">7. The motor <b>20</b> turns clockwise a predetermined number of microsteps, depending on the volume of material to be injected.</li><li id="ul0004-0008" num="0106">8. The motor <b>20</b> waits 20 seconds.</li><li id="ul0004-0009" num="0107">9. The output I/O<b>1</b> of the motor <b>20</b> is programmed to “0” and is fed to the motor <b>8</b>.</li><li id="ul0004-0010" num="0108">10. Go to step 5.</li></ul></li></ul>
0109Explanation of Additional Hardware: <ul><li id="ul0005-0001" num="0000"><ul><li id="ul0006-0001" num="0110">1. There is external power supply that is able to supply 24V <b>5</b>A. Since we are using 15 Vdc and 5 Vdc in our electronic circuit, we used a voltage regulator L7815 (U<b>1</b>) to create a 15V voltage and used a voltage regulator L7805 (U<b>3</b>) to create a 5V voltage.</li><li id="ul0006-0002" num="0111">2. In order to prevent injury to the person being treated, two sensors are provided as follows. The limit switch contact <b>16</b> connected to the connector J<b>7</b> is placed at the fully extracted “end of travel” position of the injector sub-assembly <b>300</b>. Likewise, the switch contact <b>33</b> connected to the connector J<b>5</b> is placed at the extended “end of travel” position of the piston. The 24V power is supplied to the electronic circuit and to the motors <b>8</b> and <b>20</b> through the normally closed relay K<b>1</b>. The relay's coil is permanently connected to the 12V, but is not connected to the ground. Only in case that one or both of the above-mentioned contacts <b>16</b> or <b>33</b> is shorted, whereby pin <b>1</b> of J<b>5</b> is shorted to pin <b>2</b>; and/or pin <b>1</b> of J<b>7</b> is shorted to pin <b>2</b>, then the relay's coil is connected to GND and the 24V supply to the electronic circuit and to the motors <b>8</b> and <b>20</b> is stopped instantly, without any delay. This prevents any possible disruption of the injection process, and any possible patient injury.</li></ul></li></ul>
0112In an embodiment of the invention reduced to practice, the motors that were used are SilverPak 17C/CE made by LIN Engineering of Morgan Hill, Calif. 95037, USA. This motor is combination of a step motor, controller and driver. It can communicate with a personal computer (PC) via a RS485 interface, thus allowing the motor controller to be programmed via a USB to RS485 converter card.
0113It will be appreciated that while a specific embodiment has been described, the description is non-limiting and many changes may be made without departing from the scope of the invention, which is limited only by the attached claims. For example, although semi-automatic operation has been described whereby the injector sub-assembly and the displacement sub-assembly are advanced by stepper motors under control of a programmable controller, completely manual operation may be used without the need for either the stepper motors or the programmable controller.
0114Likewise, while screw rods in association with nuts are used to convert rotary motion of the stepper motors to linear movement of the injector sub-assembly, it will be apparent that the same effect can be realized using a worm gear and linear toothed guide. The displacement sub-assembly as described is manually operated but can be automated.
0115It will also be appreciated that while in the embodiment as described, a syringe is used to inject the material, the device may include other forms of receptacle for containing the material and the material may be released using other means. By way of example, a fixed flexible container may be provided and material may be released by applying pressure to the container as is done is tubes of toothpaste and the like or by applying gas pressure. The needle may be fixed directly to a container within the casing as in the case of a syringe or it can be fixed to the casing and material can be fed to the needle from a remote source that does not necessarily have to part of the device but is coupled thereto, for example by means of a flexible tubing.
0116In order to inject material the needle must penetrate the skin to a predetermined depth of penetration, which may be preset by the manufacturer or by the user, for example by fixing to the needle a mechanical stop that may be adjustable. Alternatively, if may be controlled as disclosed in the above description using a motor. In either case, an indication of the location of the tip of the needle relative to the user's skin may be obtained via feedback from a skin sensor mounted in known spatial disposition with the needle. This may be used to alert the user that the tip of the needle is ready for injecting material promoting him or her to press a manual lever to move the needle a preset distance so as to penetrate the skin. Alternatively, it may be used to alert the user that the needle has penetrated by a preset distance so as to prompt the user to remove the needle and move it along the treatment path for the next injection. In the case of automatic devices the feedback may be used by a controller to effect penetration to the required depth.
0117Likewise, while in the embodiment as described, electrically operated stepper motors are used to move the injection sub-assembly it will readily be appreciated that other forms of power may be employed, such as manual, pneumatic and hydraulic devices. Manually operated mechanisms may be spring biased so as to adjust the tension in a spring according to a required degree of advancement or penetration of the needle, such that releasing the spring under control of a manual lever or dial or the like, moves the needle by a pre-calibrated distance.
Contents6
12 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US11633541B2 | Cited by | United States of America | Applicant |
| US11596740B2 | Cited by | United States of America | Applicant |
| US11857763B2 | Cited by | United States of America | Applicant |
| US11684713B2 | Cited by | United States of America | Applicant |
| US9925336B2 | Cited by | United States of America | Applicant |
| US11865299B2 | Cited by | United States of America | Applicant |
| US11383035B1 | Cited by | United States of America | Applicant |
| US9615847B2 | Cited by | United States of America | Applicant |
| US9452281B2 | Cited by | United States of America | Search report |
| US9616173B2 | Cited by | United States of America | Applicant |
| US11497856B2 | Cited by | United States of America | Applicant |
| US11419990B2 | Cited by | United States of America | Applicant |
| US10777319B2 | Cited by | United States of America | Applicant |
| US11929158B2 | Cited by | United States of America | Applicant |
| US10780217B2 | Cited by | United States of America | Applicant |
| US10124112B2 | Cited by | United States of America | Applicant |
| US9724124B2 | Cited by | United States of America | Search report |
| CN111447970A | Cited by | China | Search report |
| US11331425B2 | Cited by | United States of America | Applicant |
| US11020537B2 | Cited by | United States of America | Applicant |
| US11935637B2 | Cited by | United States of America | Applicant |
| USD1020794S | Cited by | United States of America | Applicant |
| US11229736B2 | Cited by | United States of America | Applicant |
| US10092703B2 | Cited by | United States of America | Applicant |
| US11364341B2 | Cited by | United States of America | Applicant |
| US11833329B2 | Cited by | United States of America | Applicant |
| US10130758B2 | Cited by | United States of America | Applicant |
| US11801344B2 | Cited by | United States of America | Applicant |
| US9402950B2 | Cited by | United States of America | Applicant |
| US10426900B2 | Cited by | United States of America | Applicant |
| US11890441B2 | Cited by | United States of America | Applicant |
| US11547841B2 | Cited by | United States of America | Applicant |
| US2009292246A1 | Cited by | United States of America | Pre-grant |
| US11628251B2 | Cited by | United States of America | Applicant |
| US11565039B2 | Cited by | United States of America | Applicant |
| US10864324B2 | Cited by | United States of America | Applicant |
| US11045603B2 | Cited by | United States of America | Applicant |
| US10052469B2 | Cited by | United States of America | Applicant |
| US11229740B2 | Cited by | United States of America | Applicant |
| US10569011B2 | Cited by | United States of America | Applicant |
| CN112869909A | Cited by | China | Search report |
| USD1024090S | Cited by | United States of America | Applicant |
| US10751478B2 | Cited by | United States of America | Applicant |
| US10898656B2 | Cited by | United States of America | Applicant |
| US10639422B2 | Cited by | United States of America | Applicant |
| US11883633B2 | Cited by | United States of America | Applicant |
| US10874803B2 | Cited by | United States of America | Applicant |
| US11957875B2 | Cited by | United States of America | Applicant |
| US11229741B2 | Cited by | United States of America | Applicant |
| US10363342B2 | Cited by | United States of America | Applicant |
| US11147931B2 | Cited by | United States of America | Applicant |
| EP2829291A4 | Cited by | European Patent Office (EPO) | Search report |
| US11369735B2 | Cited by | United States of America | Applicant |
| US10792426B2 | Cited by | United States of America | Applicant |
| US11280327B2 | Cited by | United States of America | Applicant |
| US11439754B1 | Cited by | United States of America | Applicant |
| US11738144B2 | Cited by | United States of America | Applicant |
| JPWO2013141351A1 | Cited by | Japan | Search report |
| US10973978B2 | Cited by | United States of America | Applicant |
| US11684716B2 | Cited by | United States of America | Applicant |
| US11607493B2 | Cited by | United States of America | Applicant |
| US11786668B2 | Cited by | United States of America | Applicant |
| EP2954912A1 | Cited by | European Patent Office (EPO) | Applicant |
| USD898908S | Cited by | United States of America | Applicant |
| US11944798B2 | Cited by | United States of America | Applicant |
| US11551802B2 | Cited by | United States of America | Applicant |
| US11547800B2 | Cited by | United States of America | Applicant |
| US10420883B2 | Cited by | United States of America | Applicant |
| WO2013149186A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US10786629B2 | Cited by | United States of America | Applicant |
| US11446435B2 | Cited by | United States of America | Applicant |
| US11565043B2 | Cited by | United States of America | Applicant |
| US2014324089A1 | Cited by | United States of America | Pre-grant |
| US10492990B2 | Cited by | United States of America | Applicant |
| US11324889B2 | Cited by | United States of America | Applicant |
| US11439765B2 | Cited by | United States of America | Applicant |
| US11376407B2 | Cited by | United States of America | Applicant |
| US11724027B2 | Cited by | United States of America | Applicant |
| US11839734B2 | Cited by | United States of America | Applicant |
| US9974904B2 | Cited by | United States of America | Applicant |
| US10092706B2 | Cited by | United States of America | Applicant |
| US11904140B2 | Cited by | United States of America | Applicant |
| US11724032B2 | Cited by | United States of America | Applicant |
| US2013041232A1 | Cited by | United States of America | Pre-grant |
| US10918805B2 | Cited by | United States of America | Applicant |
| US11386996B2 | Cited by | United States of America | Applicant |
| US2005187519A1 | Cites | United States of America | Pre-grant |
| US2008015503A1 | Cites | United States of America | Pre-grant |
| US2008027385A1 | Cites | United States of America | Pre-grant |
| US2009062744A1 | Cites | United States of America | Pre-grant |
| US2009062767A1 | Cites | United States of America | Pre-grant |
| US2660169A | Cites | United States of America | Pre-grant |
| US3727614A | Cites | United States of America | Pre-grant |
| US4067334A | Cites | United States of America | Pre-grant |
| US4108177A | Cites | United States of America | Pre-grant |
| US4512767A | Cites | United States of America | Pre-grant |
| US4600403A | Cites | United States of America | Pre-grant |
| US4790823A | Cites | United States of America | Pre-grant |
| US4833384A | Cites | United States of America | Pre-grant |
| US5015235A | Cites | United States of America | Pre-grant |
6 priority claims, no other members on record
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 31596410 | United States of America | P | |
| 31596410 | United States of America | P | |
| 201113050976 | United States of America | A | |
| 61315964 | – | – | – |
| US20100315964P | – | – | – |
| US201113050976 | – | – | – |
40 transactions on the USPTO file
Allowed after 1 non-final rejection and 1 final rejection.
- Non-final rejections
- 1
- Final rejections
- 1
- RCEs
- 0
- Appeals
- 0
Over time
Point at a mark for the transactionTransactions
| Event | |
|---|---|
| Surcharge for Late Payment, Micro Entity | |
| Payment of Maintenance Fee, 8th Year, Micro Entity | |
| Maintenance Fee Reminder Mailed | |
| Applicant Has Filed a Verified Statement of Micro Entity Status in Compliance with 37 CFR 1.29 | |
| Recordation of Patent Grant Mailed | |
| Patent Issue Date Used in PTA CalculationAllowed | |
| Issue Notification MailedAllowed | |
| Dispatch to FDC | |
| Application Is Considered Ready for Issue | |
| Issue Fee Payment Verified | |
| Issue Fee Payment Received | |
| Mail Notice of AllowanceAllowed | |
| Notice of Allowance Data Verification CompletedAllowed | |
| Mail Advisory Action (PTOL - 303) | |
| Advisory Action (PTOL-303) | |
| Date Forwarded to Examiner | |
| Response after Final Action | |
| Response after Final Action | |
| Mail Final Rejection (PTOL - 326)Final rejection | |
| Final RejectionFinal rejection | |
| Change in Power of Attorney (May Include Associate POA) | |
| Correspondence Address Change | |
| Date Forwarded to Examiner | |
| Response after Non-Final Action | |
| Mail Non-Final RejectionNon-final rejection | |
| Non-Final RejectionNon-final rejection | |
| Case Docketed to Examiner in GAU | |
| PG-Pub Issue Notification | |
| Application Dispatched from OIPE | |
| Application Is Now Complete | |
| Change in Power of Attorney (May Include Associate POA) | |
| Filing Receipt | |
| Sent to Classification Contractor | |
| Cleared by OIPE CSR | |
| Information Disclosure Statement considered | |
| Electronic Information Disclosure Statement | |
| Applicants have given acceptable permission for participating foreign | |
| Information Disclosure Statement (IDS) Filed | |
| IFW Scan & PACR Auto Security Review | |
| Initial Exam Team nn |
11 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| AssignmentAS | AS | |
| AssignmentAS | AS | |
| AssignmentAS | AS | |
| Fee payment procedureSURCHARGE FOR LATE PAYMENT, MICRO ENTITY (ORIGINAL EVENT CODE: M3555); ENTITY STATUS OF PATENT OWNER: MICROENTITYFEPP | FEPP | |
| Maintenance fee paymentMAFP | MAFP | |
| Fee payment procedureMAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: MICROENTITYFEPP | FEPP | |
| Fee paymentFPAY | FPAY | |
| Surcharge for late paymentSULP | SULP | |
| Maintenance fee reminder mailedREMI | REMI | |
| Fee payment procedurePATENT HOLDER CLAIMS MICRO ENTITY STATUS, ENTITY STATUS SET TO MICRO (ORIGINAL EVENT CODE: STOM); ENTITY STATUS OF PATENT OWNER: MICROENTITYFEPP | FEPP | |
| Information on status: patent grantGrantedPATENTED CASESTCF | STCF |
Numbers
- Publication
- 20110230833
- Publication, DOCDB
- 2011230833
- Publication, EPODOC
- US2011230833
- Application
- 13050976
- Application, DOCDB
- 201113050976
- Application, EPODOC
- US201113050976
Titles
- English
- Device and Method for Injecting Fluids or Gels
Patent term adjustment
- A delay
- +117 daysthe office missed an examination deadline
- Net adjustment
- 117 days
Classification
- CPC, 4
- A61M5/1456
- A61M5/46
- A61M2202/08
- A61M5/20
- IPC, 4
- A61M5 31
- A61M5 46
- A61M5 315
- A61M5 32
- USPC, 5
- 604117000
- 604187000
- 604192000
- 604207000
- 604228000